Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica
Revista Española de Quimioterapia · 2025
DOI: 10.37201/req/125.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von Ángel Rodríguez-Villodres und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain. Hauptthemen laut MEDLINE: Bordetella bronchiseptica, Bordetella Infections, Anti-Bacterial Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Human infections by Bordetella bronchiseptica are increasing in recent years. However, due to the lack of clinical susceptibility/resistance breakpoints, antimicrobial treatment is complex. Business Intelligence (BI) is a tool that allows to record and analyze large amounts of data in a very short time. The aim of this study was to analyze a cohort of patients with B. bronchiseptica infections focusing on how BI can help guide empirical antimicrobial therapy Demographic, clinical, and microbiological data about B. bronchiseptica infections were recovered. Then, MIC50/90 of several antibiotics was automatically calculated through the BI. Thirteen B. bronchiseptica infections were identified. The lowest MICs90 were for carbapenem, aminoglycoside, fluoroquinolones, and tetracyclines. The EUCAST PK-PD (non-species related) breakpoints showed that only piperacillin/tazobactam, imipenem and meropenem would be appropriate treatments to use empirically. In conclusion, BI systems have great potential to optimize the empirical antibiotic treatment in these types of infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain.
- Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. anrovi1797@gmail.com.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
- Department of Microbiology, University of Seville, Seville, Spain.
ORCID-Profile: Ángel Rodríguez-Villodres, Pedro Camacho-Martínez, José Antonio Lepe
Zitieren
APA
Rodríguez-Villodres, Á., Hoffmann-Álvarez, M. V., Camacho-Martínez, P., & Lepe, J. A. (2025). Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica. Revista Española de Quimioterapia. https://doi.org/10.37201/req/125.2024
Vancouver
Rodríguez-Villodres Á, Hoffmann-Álvarez MV, Camacho-Martínez P, Lepe JA. Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica. Revista Española de Quimioterapia. 2025. doi:10.37201/req/125.2024
BibTeX
@article{RodrguezVillodres2025,
author = {Rodríguez-Villodres, Ángel and Hoffmann-Álvarez, María Valentina and Camacho-Martínez, Pedro and Lepe, José Antonio},
title = {Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica},
journal = {Revista Española de Quimioterapia},
year = {2025},
doi = {10.37201/req/125.2024}
}
EUVIMED